Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.

Hepato-gastroenterology - 1 Mar 2007

Maruyama Shigeo, Hirayama Chisato, Horie Yutaka, Yorozu Kensho, Maeda Kazunori, Inoue Masayuki, Fujii Yasuyoshi, Umeki Kensuke, Koda Masahiko

Abstract excerpt

BACKGROUND/AIMS: Moderate polyclonal hypergammaglobulinemia is a common finding in chronic viral liver disease; however, its clinical significance has not been completely elucidated. We attempted to determine whether serum immunoglobulin levels were correlated with the disease severity and the treatment outcome in patients with chronic hepatitis C. METHODOLOGY: In a total of 102 patients with chronic hepatitis C,...

Topics

Adult
Aged
Biomarkers
Biopsy
Female
Genotype
Hepacivirus
Hepatitis C, Chronic
Humans
Immunoglobulin G
Immunoglobulins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Interferon-alpha

Liver

Male

Middle Aged

Prognosis

Statistics as Topic

Treatment Outcome

Source

Identifiers

PMID: 17523306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.PMID 17523306Read ↗

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.Semantic proximity Read ↗

The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment.Semantic proximity Read ↗

Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.Semantic proximity Read ↗

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia.Semantic proximity Read ↗

High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.Semantic proximity Read ↗

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Semantic proximity Read ↗

Viral genotypes as determinants of autoimmune expression in chronic hepatitis C.Semantic proximity Read ↗

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.Semantic proximity Read ↗

Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.